We previously reported on the partial prevention of experimental shunt-induced pulmonary arterial hypertension (PAH) by the nonselective endothelin (ET) ET-A/ET-B receptor antagonist bosentan. As the ...

Pulmonary vascular function is impaired with increased pulmonary blood flow (PBF). We hypothesized that a peroxisome proliferator–activated receptor-γ (PPAR-γ) agonist would mitigate this effect. An ...

This transcript has been edited for clarity. Vallerie McLaughlin, MD: Hello. I'm Dr Vallerie McLaughlin, the Kim A. Eagle Endowed Professor of Cardiovascular Medicine at the University of Michigan in ...

A patient with pulmonary arterial hypertension (PAH) who received a modified Potts shunt exhibited improved quality of life and exercise capacity after 1 year. A case report published in ERJ Open ...

Among patients with advanced chronic obstructive pulmonary disease (COPD), an arteriovenous (AV) shunt improves physiological parameters such as cardiac output and oxygen delivery but does not have a ...

VENOUS anastomoses connecting the portal and pulmonary veins have been shown in cirrhotic patients by post-mortem injection, 1 and there has been considerable speculation concerning their possible ...

Please provide your email address to receive an email when new articles are posted on . ANAHEIM, Calif. — A transcatheter interatrial shunt device reduced pulmonary capillary wedge pressure during ...